CANF

Can-Fite BioPharma
CANF

Overview Fund Activity

4 hedge funds and large institutions have $1.22M invested in Can-Fite BioPharma in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BRWA
1
B. Riley Wealth Advisors
Florida
$3.57K

Top Sellers

1
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$795K
3
Morgan Stanley
3
Morgan Stanley
New York
$0
4
U
4
UBS
Switzerland
$0
5
Citigroup
5
Citigroup
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$795K 222,675 -69,325 -24%
Deutsche Bank
2
Deutsche Bank
Germany
$417K 117,000 – –
BRWA
3
B. Riley Wealth Advisors
Florida
$3.57K 1,000 +1,000 New
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
– – -48,544 Closed
Morgan Stanley
5
Morgan Stanley
New York
– – -15,881 Closed
U
6
UBS
Switzerland
– – -1,500 Closed
Citigroup
7
Citigroup
New York
– – -400 Closed
Ameriprise
8
Ameriprise
Minnesota
$0 22 +22 New